Cynthia Koons –

Nasal spray approved for treating suicidal people

August 4, 2020 at 11:55 a.m.

Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about COVID-19's effect on the mental health of Americans....

New York Gov. Andrew M. Cuomo provides a coronavirus update during a press conference May 4, 2020 in Rochester.

The next COVID crisis could be a wave of suicides

May 8, 2020 at 9:47 a.m.

NEW YORK — The isolation, grief and economic hardship related to COVID-19 are creating a mental health crisis in the U.S. that researchers warn could make the already-rising suicide rate...

Valeant Pharmaceuticals has filed its long-overdue financial report for 2015, plus restated results for several quarters, resolving its default on some of its $30 billion in debt and averting other problems.

Valeant files annual report, says it will change strategy

June 8, 2018 at 1:01 p.m.

Valeant Pharmaceuticals International filed its delayed 2015 annual report in time to meet a self-imposed Friday deadline, saying it will have no additional financial restatements, is in compliance with its...

Former Valeant Pharmaceuticals CEO J. Michael Pearson speaks at the company's annual general meeting in Montreal in this 2015 photo. After a series of misseteps, Pearson agreed to step down on March 21, 2016.

After missteps, CEO of pharma firm Valeant steps down

June 8, 2018 at 9:57 p.m.

Valeant Pharmaceuticals International Inc. Chief Executive Officer Mike Pearson will step down in a shakeup of the company's board and management following a series of missteps and criticism at the...

All Stories